Vanguard Capital Management’s Lifecore Biomedical LFCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.48M Hold
1,288,621
– – ﹤0.01% 2850
2026
Q2
$6.77M Sell
1,288,621
-1,515
-0.1% -$7.63K ﹤0.01% 3003
2026
Q1
$4.8M Buy
+1,290,136
New +$8.91M ﹤0.01% 3078

Other funds holding LFCR

Vanguard Capital Management's LFCR Position: Q3 2026 in Review

Vanguard Capital Management held its Lifecore Biomedical (LFCR) position steady in Q3 2026 at 1,288,621 shares worth $8.48M. The position accounts for ﹤0.01% of the portfolio, ranked #2850.

Vanguard Capital Management first reported a position in LFCR in Q1 2026 and has held it in 3 quarters since. 93 funds tracked by Wall St. Rank hold LFCR as of Q3 2026.

  • Vanguard Capital Management held 1,288,621 shares of Lifecore Biomedical worth $8.48M as of Q3 2026.
  • Vanguard Capital Management left its Lifecore Biomedical share count unchanged in Q3 2026.
  • Lifecore Biomedical made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #2850 holding.
  • Vanguard Capital Management first reported a position in Lifecore Biomedical in Q1 2026 and has held it in 3 quarters since.
  • 93 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.